"Nugentek Life Science Co.,Ltd was established in 2004. It takes the development of health, beauty and anti-aging sciences as its professional ambition to achieve the goal of preventive medicine. ZC008 Graptopetalum paraguayense extract (GPP) is used in the development and research of new botanical drugs against liver fibrosis, liver cirrhosis, liver cancer and various organs fibrosis. We mainly cooperate with Taichung Veterans General Hospital, National Taiwan University and National Yang-Ming University. ZC008 has patents from 39 countries worldwide, including China, United States, EU, Japan and Taiwan etc.; The subsidiary company GoldenMed Biotechnology Co.,Ltd was established in 2015, and it was approved as a new pharmaceutical company through the "Biotechnology New Drug Industry Development Regulations" of the Industrial Bureau of the Ministry of Economic Affairs. This plan has also been highly recommended by the "Consortium for the Globalization of Chinese Medicine"" (CGCM) founded by Academician Yung-Chi Cheng of the Academia Sinica as the most promising new botanical drug project. At the Asian Conference on Tumor Ablation (ACTA) in 2021, Dr. Kai-Wen Huang from the Liver Cancer Research Center of National Taiwan University published "To prolong survival by combination of sorafenib and Graptopetalum paraguayense extraction (GPP) for HCC after local ablation"".
LIVER FAVOR® and HAVITAL®/Juice HA® oral hyaluronic acid series products won the 107/108 Innovation Product Award from the Ministry of Science and Technology. HAVITAL®/Juice HA® oral hyaluronic acid, LIVER FAVOR® and Bring Best® series products are also strongly recommended by many medical aesthetics, orthopedist, physiatrist and hepatobiliary gastroenterologists etc. It has been included in the 2019/20 National Pharmaceutical Yearbook for use by professional physicians and pharmacists in the guideline, it is rarely to be included. All series of products have successfully entered many medical centers, regional hospitals, clinics and other medical channels for non-health insurance prescriptions, and are actively constructing a global on-going marketing network."